A PROSPECTIVE COMPARATIVE STUDY OF INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) THERAPY WITH THE TOKYO OR CONNAUGHT STRAINS FOR NON-MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Sengiku, Atsushi
Ito, Masaaki
Miyazaki, Yu
Sawazaki, Harutake
Takahashi, Takeshi
Ogura, Keiji
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.2876
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1786
引用
收藏
页码：E734 / E734
页数：1
相关论文
共 50 条
  • [41] Renal Granulomatosis Post Intravesical Bacillus Calmette-Guerin Therapy for Non-muscle-invasive Bladder Cancer
    Tran-Harding, Karen
    Nair, Rashmi T.
    Ganesh, Halemane
    JOURNAL OF CLINICAL IMAGING SCIENCE, 2018, 8
  • [42] Does Switching Bacillus Calmette-Guerin Strains During Maintenance Therapy Affect the Outcome in Non-Muscle Invasive Bladder Cancer?
    Suer, Evren
    Karaburun, Murat Can
    Babayigit, Muammer
    Akpinar, Cagri
    Gokce, Mehmet Ilker
    Gulpinar, Omer
    Turkolmez, Kadir
    Baltaci, Sumer
    UROLOGY, 2021, 158 : 135 - 141
  • [43] Impact of bladder cancer family history on the prognosis of patients with non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin (BCG)
    Abou Chakra, Mohamad
    Duquesne, Igor
    Peyromaure, Michael
    Mott, Sarah L.
    Moussa, Mohamad
    O'Donnell, Michael A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (03) : 315 - 324
  • [44] Methylation status as a predictor of intravesical Bacillus Calmette-Guerin (BCG) immunotherapy response of high grade non-muscle invasive bladder tumor
    Husek, Petr
    Pacovsky, Jaroslav
    Chmelarova, Marcela
    Podhola, Miroslav
    Brodak, Milos
    BIOMEDICAL PAPERS-OLOMOUC, 2017, 161 (02): : 210 - 216
  • [45] Bacillus Calmette-Guerin (BCG) and alternatives Drug treatment of high-risk non-muscle invasive bladder cancer
    Leucht, K.
    Foller, S.
    Grimm, Marc-Oliver
    UROLOGE, 2021, 60 (11): : 1400 - 1408
  • [46] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Uchio, Edward M.
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Kamat, Ashish
    Packiam, Vignesh
    Anderson, Paul
    Ku, Ja Hyeon
    Chisamore, Michael
    McAdory, John
    Hnat, Nataliya
    Kim, Jee-Hyun
    Grandi, Paola
    Burke, James
    CANCER SCIENCE, 2023, 114 : 1587 - 1587
  • [47] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Li, R.
    Uchio, E.
    Steinberg, G. D.
    Shore, N.
    Anderson, P. D.
    Ben, T.
    Kamat, A.
    Keel, M.
    Packiam, V.
    McAdory, J.
    Kim, J. H.
    Chisamore, M.
    Grandi, P.
    Burke, J.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A130 - A130
  • [48] The commensal urinary microbiome as a predictor of response to Bacillus Calmette-Guerin (BCG) immunotherapy in non-muscle invasive bladder cancer
    Sweis, Randy F.
    Golan, Shay
    Barashi, Nimrod
    Hill, Elle
    Andolfi, Ciro
    Werntz, Ryan
    Bloodworth, Jeffrey
    Gajewski, Thomas
    Steinberg, Gary D.
    CANCER RESEARCH, 2019, 79 (13)
  • [49] Clinical presentation of Bacille Calmette-Guerin (BCG) infections following BCG instillation therapy of non-muscle invasive Bladder Cancer
    Nurminen, P.
    Ettala, O.
    Uusitalo-Seppala, R.
    Kaipia, A.
    Bostrom, P. J.
    EUROPEAN UROLOGY, 2022, 81 : S256 - S257
  • [50] Real-world treatment patterns among patients with non-muscle invasive bladder cancer (NMIBC) treated with intravesical Bacillus Calmette-Guerin (BCG)
    Kumar, Neela
    Balaji, Hiremagalur Parthasarathy
    Emond, Bruno
    Manceur, Ameur M.
    Ghelerter, Isabelle
    Pilon, Dominic
    Lefebvre, Patrick
    Imran, Nida Shafaat
    Ellis, Lorie
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 404 - 404
12345